Abstract
This paper concerns optimization and experimental validation of coprecipitation process parameters for preparing particles of Pyrazinamide and Polyvinylpyrrolidone using gas anti-solvent supercritical method. Mixtures of organic solvents (acetone and ethanol) were selected with various combinations of the drug and the polymer. The central composite design (CCD) was adopted to explore the effect of temperature, pressure, antisolvent addition rate, polymer fraction, and ethanol fraction on particle size distribution (PSD) and solubility. The strong likelihood models were developed for all the responses using Design-Expert software. Polymer fraction was the most important (p<0.0001) factor influencing PSD, while pressure and interaction between temperature and polymer fraction significantly affected solubility. The optimal condition was specified at temperature of 50 °C, pressure of 120 bar, antisolvent rate of 16 bar/min, polymer fraction of 30%, and ethanol fraction of 50%. The model was then validated experimentally under the optimal condition and compared with pure PZA and particles obtained from the physical mixture. According to DLS, XRD, FTIR, and FESEM analyses, the crystallinity of PZA-PVP particles was reduced in optimum conditions, leading to higher solubility. Also, the results suggest that it is feasible to produce coprecipitated particles with narrower size distribution by optimized GAS process.
Similar content being viewed by others
References
A. Silva, B. Vieira, F. Carmo, L. Amaral, L. Silva, C. Escudini, M. Lopes, V. Sousa, H. Castro, F. Veiga, C. Rodrigues, A. Ribeiro and L. Cabral, British J. Pharm. Res., 4, 1781 (2014).
D. Maher, P. Chaulet, S. Spinaci and A. Harries, Treatment of tuberculosis: guidelines for national programmes, Second edition, 2 ed., World Health Organization, Geneva (1997).
R. Varma, T. S. Kumar, B. Prasanthi and J. V. Ratna, Indian J. Pharm. Sci., 77, 258 (2015).
G. Baaklini, V. Dupray and G. Coquerel, Int. J. Pharm., 479, 163 (2015).
U. S. Kestur and L. S. Taylor, CrystEngComm, 12, 2390 (2010).
B. C. Hancock and M. Parks, Pharm. Res., 17, 397 (2000).
V. Prosapio, I. De Marco and E. Reverchon, Chem. Eng. J., 292, 264 (2016).
L. Padrela, J. Zeglinski and K. M. Ryan, Cryst. Growth Des., 17, 4544 (2017).
V. Prosapio, I. De Marco and E. Reverchon, J. Supercrit. Fluids, 138, 247 (2018).
K. Moribe, Y. Tozuka and K. Yamamoto, Adv. Drug Deliv. Rev., 60, 328 (2008).
I. Pasquali, R. Bettini and F. Giordano, Adv. Drug Deliv. Rev., 60, 399 (2008).
F. Dehghani and N. R. Foster, Curr. Opin. Solid State Mater. Sci., 7, 363 (2003).
M. Amani, N. Saadati Ardestani and N. Y. Majd, J. CO2 Utilization, 46, 101465 (2021).
I. Garay, A. Pocheville and L. Madariaga, Powder Technol., 197, 211 (2010).
S. Varona, J. Fernández, M. Rossmann and A. Braeuer, J. Chem. Eng. Data, 58, 1054 (2013).
A. Montes, M. D. Gordillo, C. Pereyra and E. J. Martínez de la Ossa, J. Supercrit. Fluids, 60, 75 (2011).
I. De Marco, M. Rossmann, V. Prosapio, E. Reverchon and A. Braeuer, Chem. Eng. J., 273, 344 (2015).
N. Foster, R. Mammucari, F. Dehghani, A. Barrett, K. Bezanehtak, E. Coen, G. Combes, L. Meure, A. Ng, H. L. Regtop and A. Tandya, Ind. Eng. Chem. Res., 42, 6476 (2003).
A. Gokhale, B. Khusid, R. N. Dave and R. Pfeffer, J. Supercrit. Fluids, 43, 341 (2007).
P. Franco, E. Reverchon and I. De Marco, Powder Technol., 340, 1 (2018).
A. Homayouni, F. Sadeghi, J. Varshosaz, H.A. Garekani and A. Nokhodchi, Eur. J. Pharm. Biopharm., 88, 261 (2014).
G. Ozkan, P. Franco, E. Capanoglu and I. De Marco, Chem. Eng. Process. — Process Intensification, 146, 107689 (2019).
İ. N. Uzun, O. Sipahigil and S. Dinçer, J. Supercrit. Fluids, 55, 1059 (2011).
F. Fusaro, M. Mazzotti and G. Muhrer, Cryst. Growth Des., 4, 881 (2004).
N. Esfandiari and S. M. Ghoreishi, J. Supercrit. Fluids, 84, 205 (2013).
C. A. Ober, S. E. Montgomery and R. B. Gupta, Powder Technol., 236, 122 (2013).
D. Jafari, I. Yarnezhad, S. M. Nowee and S. H. N. Baghban, Ind. Eng. Chem. Res., 54, 3685 (2015).
A. Shirafkan, S. M. Nowee and H. Kamali, J. Supercrit. Fluids, 178, 105386 (2021).
J. B. Ngilirabanga, M. Aucamp, P. Pires Rosa and H. Samsodien, Front. Chem., 8, 1051 (2020).
D. Medarević, J. Djuriš, S. Ibrić, M. Mitrić and K. Kachrimanis, Int. J. Pharm., 540, 150 (2018).
Z. Zhang, Q. Li, B. Guo, S. Zhang, S. Zhang and D. Hu, Sci. Rep., 10, 11187 (2020).
R. Campardelli, E. Reverchon and I. De Marco, J. Supercrit. Fluids, 143, 321 (2019).
V. Prosapio, E. Reverchon and I. De Marco, J. CO2 Utilization, 19, 230 (2017).
K. Chhouk, Wahyudiono, H. Kanda, S.-I. Kawasaki and M. Goto, Front. Chem. Sci. Eng., 12, 184 (2018).
W. J. Gun and A. F. Routh, Langmuir, 29, 12541 (2013).
S. Cherukuvada, R. Thakuria and A. Nangia, Cryst. Growth Des., 10, 3931 (2010).
A. M. Barrett, F. Dehghani and N. R. Foster, Pharm. Res., 25, 1274 (2008).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shirafkan, A., Nowee, S.M. & Kamali, H. Optimal strategies for supercritical gas antisolvent (GAS) coprecipitation of pyrazinamide/PVP particles via response surface methodology. Korean J. Chem. Eng. 39, 2307–2317 (2022). https://doi.org/10.1007/s11814-022-1142-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11814-022-1142-z